These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 17898038

  • 1. Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both.
    Mo L, Liaw L, Evan AP, Sommer AJ, Lieske JC, Wu XR.
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1935-43. PubMed ID: 17898038
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein.
    Liu Y, Mo L, Goldfarb DS, Evan AP, Liang F, Khan SR, Lieske JC, Wu XR.
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F469-78. PubMed ID: 20591941
    [Abstract] [Full Text] [Related]

  • 4. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR, Chen DH, Kaung HL, Resnick MI, Yang L.
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [Abstract] [Full Text] [Related]

  • 5. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.
    Atmani F, Glenton PA, Khan SR.
    Urol Res; 1998 May; 26(3):201-7. PubMed ID: 9694603
    [Abstract] [Full Text] [Related]

  • 6. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
    Carvalho M, Mulinari RA, Nakagawa Y.
    Braz J Med Biol Res; 2002 Oct; 35(10):1165-72. PubMed ID: 12424489
    [Abstract] [Full Text] [Related]

  • 7. Localization of tamm-horsfall protein and osteopontin in a rat nephrolithiasis model.
    Gokhale JA, Glenton PA, Khan SR.
    Nephron; 1996 Oct; 73(3):456-61. PubMed ID: 8832607
    [Abstract] [Full Text] [Related]

  • 8. The role of osteopontin on calcium oxalate crystal formation.
    Konya E, Umekawa T, Iguchi M, Kurita T.
    Eur Urol; 2003 May; 43(5):564-71. PubMed ID: 12706004
    [Abstract] [Full Text] [Related]

  • 9. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V, Kalaiselvi P, Sumitra K, Srinivasan S, Varalakshmi P.
    Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
    [Abstract] [Full Text] [Related]

  • 10. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.
    Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C, Liaw L, Alpers CE, Couser WG, Kleinman JG, Hughes J.
    J Am Soc Nephrol; 2003 Jan; 14(1):139-47. PubMed ID: 12506146
    [Abstract] [Full Text] [Related]

  • 11. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M, Nakagawa Y, Zipperle L, Hess B.
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [Abstract] [Full Text] [Related]

  • 12. Nephrocalcinosis in animal models with and without stones.
    Khan SR.
    Urol Res; 2010 Dec; 38(6):429-38. PubMed ID: 20658131
    [Abstract] [Full Text] [Related]

  • 13. Effects of Tamm-Horsfall protein with normal and reduced sialic acid content upon the crystallization of calcium phosphate and calcium oxalate in human urine.
    Hallson PC, Choong SK, Kasidas GP, Samuell CT.
    Br J Urol; 1997 Oct; 80(4):533-8. PubMed ID: 9352687
    [Abstract] [Full Text] [Related]

  • 14. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
    Hess B, Jordi S, Zipperle L, Ettinger E, Giovanoli R.
    Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
    [Abstract] [Full Text] [Related]

  • 15. Systematic analysis of modulating activities of native human urinary Tamm-Horsfall protein on calcium oxalate crystallization, growth, aggregation, crystal-cell adhesion and invasion through extracellular matrix.
    Noonin C, Peerapen P, Yoodee S, Kapincharanon C, Kanlaya R, Thongboonkerd V.
    Chem Biol Interact; 2022 Apr 25; 357():109879. PubMed ID: 35263610
    [Abstract] [Full Text] [Related]

  • 16. Tamm-Horsfall glycoprotein: role in inhibition and promotion of renal calcium oxalate stone formation studied with Fourier-transform infrared spectroscopy.
    Knörle R, Schnierle P, Koch A, Buchholz NP, Hering F, Seiler H, Ackermann T, Rutishauser G.
    Clin Chem; 1994 Sep 25; 40(9):1739-43. PubMed ID: 8070085
    [Abstract] [Full Text] [Related]

  • 17. Expression of Tamm-Horsfall protein in stone-forming rat models.
    Miyake O, Yoshioka T, Yoshimura K, Honda M, Yamaguchi S, Koide T, Okuyama A.
    Br J Urol; 1998 Jan 25; 81(1):14-9. PubMed ID: 9467470
    [Abstract] [Full Text] [Related]

  • 18. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
    Fuselier HA, Ward DM, Lindberg JS, Allen JM, Husserl FE, Marcucci PA, Cole FE, Turnipseed J, Alam J, Kok DJ.
    Urology; 1995 Jun 25; 45(6):942-6. PubMed ID: 7771027
    [Abstract] [Full Text] [Related]

  • 19. Effects of Tamm-Horsfall protein on the protection of MCDK cells from oxalate induced free radical injury.
    Hsieh N, Shih CH, Chen HY, Wu MC, Chen WC, Li CW.
    Urol Res; 2003 Mar 25; 31(1):10-6. PubMed ID: 12624657
    [Abstract] [Full Text] [Related]

  • 20. The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.
    Langdon A, Grohe B.
    Colloids Surf B Biointerfaces; 2016 Oct 01; 146():296-306. PubMed ID: 27362921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.